Alpha Tau to Participate in November Investor Conferences
JERUSALEM, November 1, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Alpha Tau to Participate in November Investor Conferences
Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Hadassah Medical Center
Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Alpha Tau Medical to Participate in September Investor Conferences
Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha
Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023
Alpha Tau & JGH Announce Alpha Dart treatment of First Patient in Pancreatic Cancer Clinical Trial
Alpha DaRT Investigator Meeting in Las Vegas
Lela’s Story of her Cancer Treatment Journey that Brought her to Alpha DaRT
Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment